ArticleIrish journal of medical science2025
Indwelling pleural catheter for malignant pleural effusion: a real-life experience in a tertiary centre with a dedicated pleural service in the Republic of Ireland.
Article in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy of a Fully Implantable Pleural Device in the Management of Complex Pleural Effusions.Current oncology (Toronto, Ont.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalignant pleural effusion (MPE) is a significant cost of burden and carries a poor prognosis with a median survival of 3-12 months. Indwelling pleural catheters (IPC) have been shown to be effective in improving symptoms in patients with MPE. This study reports our 5-year real-life experience with IPC in patients with MPE from a hospital with a dedicated pleural service in the Republic of Ireland. METHODOLOGY: This is a retrospective, single-centre study based in a tertiary hospital. All patients who had IPC inserted by the pleural service in a 5-year period (1st of January 2019 until 31 December 2023) were included in this study. Patients' clinical details and histology results were acquired via the hospital's electronic medical records.
resultsDuring the 5-year period, there were 55 patients who had IPC inserted. Symptom improvement was achieved in almost all patients (n = 54, 98.2%). Our total complication rate was low at 14.5% (n = 8), with the majority being catheter-associated skin infection. Pleurodesis was achieved in 21 (47.8%) patients with the mean and median time to pleurodesis were 115.5 days and 94 days, respectively.
conclusionIPC is a relatively safe procedure with low complication rates when performed by trained physicians. The additional support of a dedicated pleural service will maximize the benefits of IPC while reducing the complication rates.
Indexed as
Identifiers
40663306What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.